Additive Manufacturing Strategy Steering Group (AM UK)
Additive Manufacturing: the national strategy illustrated by the challenges and opportunities of using AM in medical applications
Today additive manufacturing is no-longer an aspirational technology, it is a ‘Must Have’ for the UK’s High Value Manufacturing sector to remain competitive globally. The national strategy published in September 2017 provides recommendations to enable UK industry to unlock the full commercial potential of additive manufacturing and presents the output of 3 years of work undertaken by the UK AM community.
This presentation on the UK’s national AM strategy will be illustrated by the challenges faced by one of the highly regulated industry sectors. For the MedTech industry, additive manufacturing provides significant potential benefits but to integrate and commercialised AM is a complex and demanding process with challenges including design considerations, process control, the cleaning and validation of implantable devices and a dynamic regulatory environment.
Paul Unwin is the Co-chair of the Additive Manufacturing Strategy Steering Group (AM UK). Previously, Dr Unwin was the founding CEO of the Stanmore Implants Worldwide Ltd, who are a world renowned specialist orthopaedic implant service provider. Paul was the creator and architect of a ground-breaking patient-specific implant system that integrated patient imaging, implant design, implant manufacture utilising Additive Manufacturing and placing the implants with the aid of robotics, culminating in the successful surgical placement - a world first. Paul and his team began investigating additive manufacturing for orthopaedic implants in 2006 and after following an extensive development programme built and implanted one of the first additive manufactured bone replacements in 2011.
View the list of companies which exhibited at Additive International 2018
Supporters & Media Partners 2018